🔴 Veradermics is trading 4.5% down today amid Nasdaq and S&P 500 declines

Veradermics is trading 4.5% down at $112.83, with the decline appearing aligned with broader risk-off trading; no fresh company-specific catalyst was identified.

• No company announcement, earnings release, or FDA action was identified for September 23, 2026.
• The Nasdaq is down 0.79%, and the S&P 500 is down 0.46%.
• Investors remain focused on upcoming VDPHL01 clinical milestones; recent conference commentary was not a fresh catalyst for this session.